- €601.68m
- €943.68m
- €1.21bn
- 68
- 94
- 10
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 950 | 847 | 923 | 1,115 | 1,211 |
Cost of Revenue | |||||
Gross Profit | 300 | 252 | 290 | 348 | 385 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 859 | 830 | 835 | 1,006 | 1,080 |
Operating Profit | 90.9 | 17.2 | 87.7 | 109 | 131 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 77.7 | 5.2 | 77 | 97.3 | 112 |
Provision for Income Taxes | |||||
Net Income After Taxes | 59.8 | -8.8 | 58.4 | 74.3 | 85.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 57.3 | -12 | 54.4 | 67.6 | 81.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 57.3 | -12 | 54.4 | 67.7 | 81.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.96 | 0.994 | 2.64 | 3.52 | 3.62 |
Dividends per Share |